T-Cell Response to TB Infection: High-Resolution Imaging Reveals Major Differences Between Lab and Live Results.
Volunteer for NIAID-funded clinical studies related to tuberculosis on ClinicalTrials.gov.
An ancient disease, TB remains one of the major causes of disability and death worldwide. In 2010, an estimated 8.8 million people fell ill with TB, including 1.1 million cases among people with HIV, according to the World Health Organization. Of the 1.4 million deaths, 95 percent occurred in developing countries. NIAID is part of the global research community that is committed to finding new ways to better understand, diagnose, treat, and ultimately prevent TB. More about NIAID TB Research.
Multidrug-resistant and Extensively Drug-resistant Tuberculosis Research Agenda (PDF)
NIAID’s Role in Addressing TB, Drug-Resistant TB, and TB in People with HIV/AIDS
New TB Resource at PATRIC Bioinformatics Resource Center
Statement: World TB Day—March 21, 2013
NIH-Funded Trial Launched to Assess Experimental TB Drug—Dec. 11, 2012
Media Availability: Antibiotic Shows Promise in Treating Extensively Drug-Resistant Tuberculosis—Oct. 18, 2012
All TB News Releases
News from NIAID-Supported Institutions
Last Updated March 21, 2013